Shares of AbbVie Inc. ABBV slumped 0.26% to $192.94 Wednesday, on what proved to be an all-around rough trading session for ...

Even more alarming is AbbVie's payout ratio of 216.7%, far surpassing the peer average of 141%. This sky-high figure means ...

Just a few short weeks after winning an FDA Fast Track tag for its investigational BTK degrader in certain blood cancers, ...

AbbVie Inc.’s TV advertisements featuring tennis legend Serena Williams make misleading claims about the effectiveness of its ...

The stock's fall snapped a two-day winning streak.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.

Pharmaceutical giant AbbVie has sued cancer treatment maker BeiGene in Chicago federal court, accusing it of stealing trade ...

The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...

The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...

NFL Week 3 power rankings: Saints and Buccaneers skyrocket, Cowboys and Ravens fall September harvest moon will provide ...

The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...

AbbVie's longtime CEO, Richard Gonzalez, who held his position since the business spun off from Abbott Laboratories in 2013, ...